reproductive Flashcards

1
Q

BV

A

Bacterial vaginosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

AMN

A

Amniocenteis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

L & D

A

Labor & Delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HRT

A

Hormone replacement therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HPV

A

Human papilloma virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

IUD

A

Intrauterine device

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PID

A

Pelvic inflammatory disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Trich

A

Trichomoniasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Menarche

A

Beginning of menstrual function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Menopause

A

Normal termination of menstrual function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Perimenopause

A

Transition phase between regular menstrual periods and no periods at all

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Amenorrhea

A

Abnormal absence of menstrual periods for 3 or more months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dysmenorrhea

A

Pain caused by uterine cramps during menstrual period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Estradiol

A

Estrogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Estradiol MOA

A

Developing & maintaining female reproductive system & secondary sex characteristics
Involved in shaping skeleton and inhibiting bone resorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Estradiol indications

A

Treatment of moderate to severe vasomotor symptoms

Prevention of osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Estradiol adverse effects

A

Vaginal bleeding, breast tenderness, nausea and vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Estradiol key facts

A

Contraindications: pregnancy, undiagnosed vaginal bleeding; known or suspected breast cancer, active thromboembolic disorder, severe liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Estradiol counseling

A

Increase risk of endometrial carcinoma in postmenopausal women
Women with uterus should also receive monthly progestins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Medroxyprogesterone

A

Progestins

21
Q

Medroxyprogesterone MOA

A

Inhibit secretion of gonadtropins

22
Q

Medroxyprogesterone indications

A

Prevention of pregnancy

Abnormal uterine bleeding due to hormonal imbalance

23
Q

Medroxyprogesterone adverse effects

A

Breakthrough bleeding, nausea

24
Q

Depo-Provera injection key facts

A

May lose significant bone mineral density

Used as long term birth control method (> 2 years) only if other birth control methods are inadequate

25
Q

Medroxyprogesterone counseling

A

Progestin withdrawal bleeding occurs within 3 – 7 days after discontinuing oral therapy

26
Q

Depo-Provera counseling

A

At beginning of therapy, menstrual cycle may be disrupted and irregular and unpredictable bleeding or spotting may occur

27
Q

Norgestrel / ethinyl estradiol

A

Monophasic Oral Contraceptive

28
Q

Norgestrel / ethinyl estradiol MOA

A

Inhibit ovulation by suppressing gonadotropins , follicle stimulating hormone (FSH) and luteinizing hormone (LH).

29
Q

Norgestrel / ethinyl estradiol indication

A

Prevention of pregnancy in women, treatment of menorrhagia, pain associated with endometriosis, dysmenorrhea

30
Q

Norgestrel / ethinyl estradiol adverse effects

A

Nausea, vomiting, bloating, migraine headaches, edema, breast tenderness, breakthrough bleeding, change in menstrual flow, weight gain, tiredness, fatigue, depression

31
Q

Norgestrel / ethinyl estradiol key facts

A

Prescribed with caution if ever, to smokers, > 35 years of age
Smokers < 30 years of age who are otherwise healthy generally can use combined oral contraceptives

32
Q

Norgestrel / ethinyl estradiol counseling

A

Take at same time each day
Spotting or breakthrough bleeding during first few months of therapy
Use additional method of birth control during first week of pills during initial cycle of OC pills
Notify healthcare provider if pregnancy suspected

33
Q

Desogestrel / ethinyl estradiol MOA

A

Inhibit ovulation by suppressing gonadotropins , follicle stimulating hormone (FSH) and luteinizing hormone (LH).

34
Q

Desogestrel / ethinyl estradiol indications

A

Prevention of pregnancy in women

35
Q

Desogestrel / ethinyl estradiol

A

Biphasic Oral Contraceptive

36
Q

Norethindrone / ethinyl estradiol MOA

A

Inhibit ovulation by suppressing gonadotropins , follicle stimulating hormone (FSH) and luteinizing hormone (LH).

37
Q

Norethindrone / ethinyl estradiol indications

A

Prevention of pregnancy in women

Treatment of moderate acne vulgaris in women ≥ 15 years of age

38
Q

Norethindrone / ethinyl estradiol

A

Triphasic Oral Contraceptive

39
Q

Norethindrone MOA

A

***Suppresses ovulation in approximately 50% of users

40
Q

Norethindrone indications

A

Prevention of pregnancy in women

41
Q

Norethindrone adverse effects

A

Breakthrough bleeding, nausea

42
Q

Norethindrone

A

Progestin-Only Oral Contraceptives

43
Q

Norethindrone counseling

A

Effectiveness may be dramatically reduced when taken > 3 hours late
Appropriate action if one or more progestin-only pills are missed

44
Q

Raloxifene MOA

A

Inhibits bone resorption

Reduces biochemical markers of bone turnover

45
Q

Raloxifene indications

A

Prevention and treatment of postmenopausal osteoporosis

Risk reduction of invasive breast cancer in

46
Q

Raloxifene

A

Selective Estrogen Receptor Modulator (SERMs)

47
Q

Raloxifene adverse effects

A

Hot flashes, nausea

48
Q

Raloxifene key facts

A

Avoid in patients with history of thromboembolic disorders

49
Q

Raloxifene counseling

A

Discontinue at least 72 hours prior to and during prolonged immobilization to prevent clot formations
Avoid prolonged restrictions of movement during travel